Test Price
2,800 AED✅ Home Collection Available
IL2 Gene (Severe Combined Immunodeficiency due to IL2 Deficiency) Genetic Test in UAE – 2800 AED
Executive Summary & Core Metrics
✅ Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 validated NGS processing.
✅ Premium Logistics: VIP Mobile Phlebotomy & temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
✅ Clinical Guidance: Telephonic post-test consultation with a Consultant Medical Genetics for result interpretation.
✅ Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Price: 2,800 AED (all-inclusive, no hidden fees).
Turnaround Time: 3–4 weeks from sample receipt.
Sample Type: Peripheral whole blood, FTA card, or extracted DNA.
DHA Facility License: 1143 – Dubai Healthcare City.
Test Overview & Methodology
The IL2 Gene (SCID due to IL2 Deficiency) NGS Test is a comprehensive genetic analysis that identifies pathogenic variants in the IL2 gene, enabling early diagnosis and tailored management of a rare, life-threatening primary immunodeficiency. This test empowers UAE families with definitive molecular answers, aligning with international standards for precision medicine in immunology.
| Feature | Our Test (NGS Panel) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Technology | Next‑Generation Sequencing (NGS) | Sanger Sequencing |
| Coverage | Full IL2 gene coding regions & selected intronic boundaries | Targeted hotspot variants only |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Diagnostic Sensitivity | >99.9% (ISO 9001:2015 validated) | ~85% |
Physician Insight & Safety Protocols
🩺 Lina Osama Zaki Quteineh – Consultant Medical Genetics (DHA Registration ID: 9294403)
“A positive IL2 mutation result must be interpreted in the context of immune function panels, lymphocyte subset analysis, and the full clinical picture. Early molecular confirmation can open doors to life-saving interventions such as hematopoietic stem cell transplantation or gene therapy. My team is committed to guiding each family through every clinical step with clarity and compassion.”
Medication Safety Advisory
⚠️ Important Pre-Test Caution
Never alter or stop any prescribed treatment regimen without direct consultation with your managing immunologist. This genetic test serves as a diagnostic complement; all therapeutic decisions must be made by your healthcare provider based on the complete clinical profile.
Safety Exclusion & Emergency Red Flags
🚨 Collection Contraindications & Urgent Warning Signs
- Active severe infection or fever – postpone sample collection until clinically stable.
- Known anaphylaxis to local anaesthetics used during venipuncture.
- Emergency Red Flags: If the patient experiences sudden respiratory distress, cyanosis, or signs of septic shock, proceed immediately to the nearest emergency department – do not delay care while awaiting test results.
Patient FAQ & Clinical Guidance
1. What is the IL2 gene NGS test, and why is it recommended?
The IL2 gene NGS analyzes your DNA to detect mutations causing severe combined immunodeficiency (SCID) due to IL2 deficiency, a hereditary condition that impairs the immune system from birth. It is recommended for infants with recurrent, unexplained severe infections, failure to thrive, or a family history of SCID, providing a definitive molecular diagnosis that guides life-saving treatments such as bone marrow transplant or gene therapy.
2. How is the sample collected, and is home collection truly hospital-grade?
A trained phlebotomist collects a small blood sample (or one drop on an FTA card, or previously extracted DNA) using sterile, single-use equipment, transported at 2–8°C in a validated cold-chain system that meets DHA and international standards. Our VIP home collection service operates 8 AM – 11 PM daily, bringing ICU-level care to your doorstep with full temperature-controlled logistics.
3. What do the results mean, and how will I understand them?
A positive result confirms the presence of a disease-causing variant in the IL2 gene, establishing a diagnosis of IL2-deficiency SCID. It does not predict severity but allows early intervention planning. You will receive a comprehensive report reviewed by our Consultant Medical Genetics, followed by a telephonic consultation to explain the implications and next steps, with a clear pathway to connect you with UAE-based immunology specialists.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Security: All genomic data is processed and stored in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genetic information is encrypted, access-controlled, and never shared without explicit consent.
Clinical Safety & Consent: Sample collection and testing adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient safety, informed consent, and professional accountability throughout the diagnostic pathway.
Accreditation: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License: 1143. Corporate Lab: DNA Labs UAE.
Clinical & Logistical Metadata
| Test Name | IL2 Gene (Severe Combined Immunodeficiency due to IL2 Deficiency) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood, FTA Card, or Extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | D81.2 |
| LOINC Code | 94221-7 |
| DHA Facility License & Laboratory Address | License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians